+44 (0)20 3910 4640 hello@symmetron.net

Idiopathic Pulmonary Fibrosis

 

The burden of illness of idiopathic pulmonary fibrosis:
a comprehensive evidence review

PharmacoEconomics. 2018;36:779–807

Awards

Top PharmacoEconomics article of 2018!

Downloads and counting

Authors

Diamantopoulos A, Wright E, Vlahopoulou K, Cornic L, Schoof N, Maher TM

Process

\

Comprehensive review of economic evaluations, resource use and quality of life literature

\

Critical appraisal of study quality and applicability

\

Qualitative and quantitative summary of burden of disease compared with healthy population

Publications in other disease areas

Atrial fibrillation

Cost-effectiveness of an insertable cardiac monitor to detect atrial fibrillation in patients with cryptogenic stroke

Cancer

Societal costs of Er+/Her2- advanced or metastatic breast cancer in post-menopausal women in the United Kingdom

Idiopathic pulmonary fibrosis

The burden of illness of idiopathic pulmonary fibrosis: a comprehensive evidence review

Psoriasis

The comparative efficacy of brodalumab in patients with moderate-to-severe psoriasis: a systematic literature review and network meta-analysis

Rheumatoid arthritis

Tocilizumab in the treatment of rheumatoid arthritis: a cost-effectiveness analysis in the UK

 

Venous thromboembolism

Cost-effectiveness of rivaroxaban in the prevention of venous thromboembolism: A Canadian analysis using the Ontario Ministry of Health Perspective